Angiodynamics (ANGO) Non-Current Debt (2011 - 2023)

Angiodynamics (ANGO) has reported Non-Current Debt for 13 consecutive years, with $49.8 million the latest figure, recorded in Q2 2023.

• For the quarter ending Q2 2023, Non-Current Debt rose 99.27% year-over-year to $49.8 million; the trailing twelve-month figure through May 2023 stood at $49.8 million (up 99.27% YoY), and the FY2023 full-year result was $49.8 million, up 99.27% from the prior year.
• Non-Current Debt steadied at $49.8 million in Q2 2023 per ANGO's latest filing, from $49.8 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $133.1 million in Q1 2019 and bottomed at $14.3 million in Q1 2020.
• Historically, Non-Current Debt has averaged $46.3 million across 5 years, with a median of $40.0 million in 2020.
• The sharpest annual moves came in 2020 and 2021: Non-Current Debt tumbled 89.22% in 2020, then jumped 109.19% in 2021.
• Over 5 years, Non-Current Debt stood at $124.4 million in 2019, then sank by 67.85% to $40.0 million in 2020, then slumped by 37.5% to $25.0 million in 2021, then surged by 99.18% to $49.8 million in 2022, then increased by 0.04% to $49.8 million in 2023.
• According to Business Quant data, Non-Current Debt over the past three periods registered $49.8 million, $49.8 million, and $49.8 million for Q2 2023, Q1 2023, and Q4 2022 respectively.